Synthetic biology could provide solution to bird flu
Synthetic biology is being used in the hunt for a vaccine for H7N9, the new strain of bird flu emerging in China, with hopes it could shave a vital two weeks off the development process...
David O'Rourke
David O’Rourke is a Volunteer Writer at BioNews. He is the Co-Founder, Chief Strategic Officer and Chief Scientific Officer at ProFertility, which is leading a revolution in healthcare. Previously he was the Creator, Co-Founder, Chief Scientific Officer and Chief Innovation Officer of Bea Fertility, an innovative fertility company reimagining fertility treatment. David has ten years of experience working as a Senior Clinical Embryologist in central London, and has also spent periods at Merck and Vitrolife across Europe, the Middle East and Africa, working with a range of clinical, research and innovation institutions. His clinical research focused on social oocyte freezing and egg banking, and oocyte activation.
BioNews Articles by David O'Rourke
Cancer genetics: plans for London-based Tumour Profiling Unit unveiled
The planned Tumuor Profiling Unit at The Institute for Cancer Research, London will focus on sequencing the DNA of cancer tumours to help diagnose and monitor different types of cancer, and to also identify those more likely to respond to particular treatments....